80 related articles for article (PubMed ID: 9669392)
1. P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy.
Kostakoglu L; Guc D; Canpinar H; Kars A; Alper E; Kiratli P; Hayran M; Gündüz U; Kansu E
J Nucl Med; 1998 Jul; 39(7):1191-7. PubMed ID: 9669392
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the P-glycoprotein expression by 99mTc-MIBI bone marrow imaging in patients with untreated leukaemia.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Nucl Med Commun; 2003 Apr; 24(4):397-402. PubMed ID: 12673168
[TBL] [Abstract][Full Text] [Related]
3. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
4. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
5. MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy.
Ak Y; Demirel G; Gülbas Z
Nucl Med Commun; 2007 Jul; 28(7):541-6. PubMed ID: 17538395
[TBL] [Abstract][Full Text] [Related]
6. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.
Kostakoglu L; Kiratli P; Ruacan S; Hayran M; Emri S; Ergün EL; Bekdik CF
J Nucl Med; 1998 Feb; 39(2):228-34. PubMed ID: 9476923
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
11. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
12. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Catalano L; Pace L; Rotoli B; Salvatore M
Cancer Biother Radiopharm; 2004 Apr; 19(2):165-70. PubMed ID: 15186596
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression, encoded by the multidrug resistance gene-1 messenger ribonucleic acid, in intracranial meningiomas.
Kunishio K; Morisaki K; Matsumoto Y; Nagao S; Nishiyama Y
Neurol Med Chir (Tokyo); 2003 Dec; 43(12):573-80; discussion 581. PubMed ID: 14723263
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m MIBI liver imaging for hepatocellular carcinoma: correlation with P-glycoprotein-multidrug-resistance gene expression.
Chang CS; Yang SS; Yeh HZ; Kao CH; Chen GH
Hepatogastroenterology; 2004; 51(55):211-4. PubMed ID: 15011866
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein.
De Moerloose B; Van de Wiele C; Dhooge C; Philippé J; Speleman F; Benoit Y; Laureys G; Dierckx RA
Eur J Nucl Med; 1999 Apr; 26(4):396-403. PubMed ID: 10199946
[TBL] [Abstract][Full Text] [Related]
18. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIBI uptake in breast cancer.
Kostakoglu L; Ruacan S; Ergün EL; Sayek I; Elahi N; Bekdik CF
J Nucl Med; 1998 Jun; 39(6):1021-6. PubMed ID: 9627337
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
Ugur O; Bozkurt MF; Hamaloglu E; Sokmensuer C; Etikan I; Ugur Y; Sayek I; Gulec SA
Arch Surg; 2004 Nov; 139(11):1175-9. PubMed ID: 15545562
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]